Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
According to our (Global Info Research) latest study, the global Cerebral Embolic Protection Devices for TAVI market size was valued at US$ 66.6 million in 2023 and is forecast to a readjusted size of USD 318 million by 2030 with a CAGR of 25.3% during review period.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report is a detailed and comprehensive analysis for global Cerebral Embolic Protection Devices for TAVI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Cerebral Embolic Protection Devices for TAVI market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Cerebral Embolic Protection Devices for TAVI market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Cerebral Embolic Protection Devices for TAVI market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Cerebral Embolic Protection Devices for TAVI market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cerebral Embolic Protection Devices for TAVI
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cerebral Embolic Protection Devices for TAVI market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific (Claret Medical), Venus Medtech (Keystone Heart), Transverse Medical, Innovative Cardiovascular Solutions, Protembis GmbH, Filterlex Medical, Emboline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cerebral Embolic Protection Devices for TAVI market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Total Artery Coverage
Non-total Artery Coverage
Market segment by Application
Hopsital
Others
Major players covered
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cerebral Embolic Protection Devices for TAVI product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cerebral Embolic Protection Devices for TAVI, with price, sales quantity, revenue, and global market share of Cerebral Embolic Protection Devices for TAVI from 2019 to 2024.
Chapter 3, the Cerebral Embolic Protection Devices for TAVI competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cerebral Embolic Protection Devices for TAVI breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Cerebral Embolic Protection Devices for TAVI market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Embolic Protection Devices for TAVI.
Chapter 14 and 15, to describe Cerebral Embolic Protection Devices for TAVI sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Cerebral Embolic Protection Devices for TAVI. Industry analysis & Market Report on Cerebral Embolic Protection Devices for TAVI is a syndicated market report, published as Global Cerebral Embolic Protection Devices for TAVI Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cerebral Embolic Protection Devices for TAVI market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.